PetIQ (PETQ) Stock Forecast, Price Target & Predictions
PETQ Stock Forecast
PetIQ stock forecast is as follows: an average price target of $31.00 (represents a 0.78% upside from PETQ’s last price of $30.76) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
PETQ Price Target
The average price target for PetIQ (PETQ) is $31.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $31.00 to $31.00. This represents a potential 0.78% upside from PETQ's last price of $30.76.
PETQ Analyst Ratings
According to 3 Wall Street analysts, PetIQ's rating consensus is 'Buy'. The analyst rating breakdown for PETQ stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
PetIQ Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 08, 2024 | Bill Chappell | Truist Financial | $31.00 | $30.42 | 1.91% | 0.78% |
The latest PetIQ stock forecast, released on Aug 08, 2024 by Bill Chappell from Truist Financial, set a price target of $31.00, which represents a 1.91% increase from the stock price at the time of the forecast ($30.42), and a 0.78% increase from PETQ last price ($30.76).
PetIQ Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $31.00 | $31.00 |
| Last Closing Price | $30.76 | $30.76 | $30.76 |
| Upside/Downside | -100.00% | 0.78% | 0.78% |
In the current month, the average price target of PetIQ stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to PetIQ's last price of $30.76. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 07, 2024 | William Blair | - | Market Perform | Downgrade |
| Oct 25, 2022 | Raymond James | Outperform | Outperform | Hold |
| Nov 30, 2021 | Benchmark | - | Buy | Initialise |
PetIQ's last stock rating was published by William Blair on Aug 07, 2024. The company Downgrade its PETQ rating from "null" to "Market Perform".
PetIQ Financial Forecast
PetIQ Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $219.93K | $277.02M | $314.55K | $290.47M | $184.08M | $209.72M | - | $275.69M | $196.64M | $210.53M | $271.01M | $254.35M | $164.21M | $162.08M | $266.98M | $186.78M | $154.34M | $186.03M |
| Avg Forecast | $268.41M | $328.84M | $373.30M | $343.10M | $247.36M | $307.60M | $347.70M | $323.54M | $230.22M | $286.56M | $330.14M | $300.43M | $189.04M | $229.06M | $273.77M | $277.15M | $192.48M | $204.33M | $259.40M | $269.45M | $173.35M | $196.82M | $304.60M | $210.19M | $146.08M | $166.28M | $251.50M | $176.94M | $130.28M | $173.26M |
| High Forecast | $276.83M | $339.16M | $385.02M | $353.88M | $255.13M | $317.25M | $358.62M | $333.70M | $237.45M | $291.45M | $340.50M | $309.86M | $191.83M | $236.25M | $282.36M | $285.86M | $198.52M | $210.75M | $259.40M | $282.54M | $181.77M | $206.38M | $319.40M | $220.40M | $153.18M | $174.37M | $263.72M | $185.54M | $136.61M | $181.68M |
| Low Forecast | $258.43M | $316.62M | $359.43M | $330.36M | $238.17M | $296.17M | $334.78M | $311.52M | $221.67M | $278.15M | $317.87M | $289.27M | $187.35M | $220.55M | $263.59M | $266.86M | $185.33M | $196.74M | $259.40M | $259.24M | $166.78M | $189.36M | $293.05M | $202.22M | $140.54M | $159.98M | $241.96M | $170.24M | $125.34M | $166.69M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 9 | 8 | 7 | 6 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.21% | 0.00% | 1.05% | 0.96% | 1.03% | - | 1.02% | 1.13% | 1.07% | 0.89% | 1.21% | 1.12% | 0.97% | 1.06% | 1.06% | 1.18% | 1.07% |
PetIQ's average Quarter revenue forecast for Mar 24 based on 4 analysts is $300.43M, with a low forecast of $289.27M, and a high forecast of $309.86M. PETQ's average Quarter revenue forecast represents a 136503.97% increase compared to the company's last Quarter revenue of $219.93K (Dec 23).
PetIQ EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 9 | 8 | 7 | 6 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-9.94K | $9.36M | $18.72K | $27.42M | $1.64M | $13.52M | - | $18.37M | $5.92M | $7.11M | $19.53M | $19.33M | $7.57M | $7.08M | $10.46M | $6.90M | $-4.30M | $3.50M |
| Avg Forecast | $15.56M | $19.07M | $21.65M | $19.90M | $14.34M | $17.84M | $20.16M | $18.76M | $13.35M | $16.62M | $19.14M | $16.74M | $10.96M | $13.28M | $15.88M | $15.21M | $11.16M | $9.00M | $15.04M | $13.83M | $10.05M | $7.11M | $21.67M | $15.19M | $7.57M | $17.13M | $4.86M | $5.18M | $7.55M | $1.87M |
| High Forecast | $16.05M | $19.67M | $22.33M | $20.52M | $14.79M | $18.40M | $20.80M | $19.35M | $13.77M | $16.90M | $19.75M | $20.08M | $11.12M | $13.70M | $16.37M | $18.26M | $11.51M | $10.80M | $15.04M | $16.60M | $10.54M | $8.54M | $26.00M | $18.22M | $9.08M | $20.55M | $5.83M | $6.21M | $7.92M | $2.24M |
| Low Forecast | $14.99M | $18.36M | $20.84M | $19.16M | $13.81M | $17.17M | $19.41M | $18.06M | $12.85M | $16.13M | $18.43M | $13.39M | $10.86M | $12.79M | $15.29M | $12.17M | $10.75M | $7.20M | $15.04M | $11.07M | $9.67M | $5.69M | $17.33M | $12.15M | $6.06M | $13.70M | $3.89M | $4.14M | $7.27M | $1.49M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.00% | 0.70% | 0.00% | 1.80% | 0.15% | 1.50% | - | 1.33% | 0.59% | 1.00% | 0.90% | 1.27% | 1.00% | 0.41% | 2.15% | 1.33% | -0.57% | 1.87% |
5 analysts predict PETQ's average Quarter EBITDA for Dec 23 to be $10.96M, with a high of $11.12M and a low of $10.86M. This is 17.18% upper than PetIQ's previous annual EBITDA (Sep 23) of $9.36M.
PetIQ Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 9 | 8 | 7 | 6 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-17.49K | $451.00K | $9.47K | $9.70M | $-6.89M | $-49.57M | - | $3.13M | $-14.47M | $-7.90M | $4.03M | $2.03M | $-10.42M | $-63.06M | $-1.89M | $-2.10M | $-10.99M | $-5.89M |
| Avg Forecast | $5.96M | $20.38M | $26.44M | $24.84M | $4.54M | $16.25M | $20.61M | $24.11M | $465.86K | $14.21M | $17.63M | $2.86M | $-11.02M | $583.50K | $9.08M | $2.60M | $-3.28M | $-10.00M | $11.69M | $2.36M | $525.47K | $-7.90M | $4.47M | $1.60M | $-10.42M | $-152.53M | $-878.26K | $-1.58M | $1.61M | $-3.15M |
| High Forecast | $6.21M | $21.21M | $27.52M | $25.85M | $4.73M | $16.91M | $21.46M | $25.09M | $484.87K | $14.60M | $18.35M | $3.43M | $-7.60M | $607.31K | $9.46M | $3.12M | $-3.13M | $-8.00M | $11.69M | $2.83M | $558.67K | $-6.32M | $5.36M | $1.92M | $-8.34M | $-122.02M | $-702.61K | $-1.26M | $1.71M | $-2.52M |
| Low Forecast | $5.68M | $19.39M | $25.16M | $23.64M | $4.32M | $15.46M | $19.62M | $22.94M | $443.35K | $13.52M | $16.78M | $2.29M | $-15.58M | $555.31K | $8.65M | $2.08M | $-3.42M | $-12.00M | $11.69M | $1.89M | $499.58K | $-9.48M | $3.57M | $1.28M | $-12.50M | $-183.03M | $-1.05M | $-1.89M | $1.53M | $-3.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 0.77% | 0.00% | 3.73% | 2.10% | 4.96% | - | 1.33% | -27.55% | 1.00% | 0.90% | 1.27% | 1.00% | 0.41% | 2.15% | 1.33% | -6.84% | 1.87% |
PetIQ's average Quarter net income forecast for Dec 23 is $-11.02M, with a range of $-15.58M to $-7.60M. PETQ's average Quarter net income forecast represents a -2543.48% decrease compared to the company's last Quarter net income of $451.00K (Sep 23).
PetIQ SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 9 | 8 | 7 | 6 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $42.73K | $55.02M | $55.16K | $43.33M | $37.75M | $45.98M | - | $48.24M | $41.45M | $45.25M | $43.14M | $40.67M | $32.63M | $35.56M | $38.49M | $31.69M | $28.87M | $29.34M |
| Avg Forecast | $47.12M | $57.73M | $65.53M | $60.23M | $43.42M | $54.00M | $61.04M | $56.80M | $40.41M | $50.30M | $57.95M | $44.02M | $33.18M | $40.21M | $48.06M | $40.02M | $33.79M | $57.24M | $45.54M | $36.38M | $30.43M | $45.25M | $47.86M | $31.96M | $32.63M | $86.02M | $17.88M | $23.77M | $22.87M | $15.68M |
| High Forecast | $48.60M | $59.54M | $67.59M | $62.12M | $44.79M | $55.69M | $62.95M | $58.58M | $41.68M | $51.16M | $59.77M | $52.82M | $33.67M | $41.47M | $49.57M | $48.02M | $34.85M | $68.69M | $45.54M | $43.66M | $31.91M | $54.30M | $57.43M | $38.35M | $39.16M | $103.22M | $21.45M | $28.52M | $23.98M | $18.81M |
| Low Forecast | $45.37M | $55.58M | $63.10M | $57.99M | $41.81M | $51.99M | $58.77M | $54.69M | $38.91M | $48.83M | $55.80M | $35.22M | $32.89M | $38.72M | $46.27M | $32.01M | $32.53M | $45.80M | $45.54M | $29.10M | $29.28M | $36.20M | $38.29M | $25.57M | $26.10M | $68.81M | $14.30M | $19.01M | $22.00M | $12.54M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.37% | 0.00% | 1.08% | 1.12% | 0.80% | - | 1.33% | 1.36% | 1.00% | 0.90% | 1.27% | 1.00% | 0.41% | 2.15% | 1.33% | 1.26% | 1.87% |
PetIQ's average Quarter SG&A projection for Mar 24 is $44.02M, based on 4 Wall Street analysts, with a range of $35.22M to $52.82M. The forecast indicates a 102920.93% rise compared to PETQ last annual SG&A of $42.73K (Dec 23).
PetIQ EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 10 | 10 | 9 | 8 | 7 | 6 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.60 | $0.02 | $0.32 | $0.33 | $-0.24 | $-1.70 | - | $0.11 | $-0.50 | $-0.27 | $0.14 | $0.08 | $-0.41 | $-2.53 | $-0.08 | $-0.09 | $-0.47 | $-0.26 |
| Avg Forecast | $0.17 | $0.58 | $0.76 | $0.71 | $0.13 | $0.47 | $0.59 | $0.69 | $0.01 | $0.41 | $0.50 | $0.43 | $-0.32 | $0.02 | $0.26 | $0.35 | $-0.09 | $0.06 | $0.34 | $0.37 | $0.02 | $0.09 | $0.73 | $0.14 | $-0.10 | $0.16 | $0.45 | $0.16 | $0.06 | $0.35 |
| High Forecast | $0.18 | $0.61 | $0.79 | $0.74 | $0.14 | $0.48 | $0.61 | $0.72 | $0.01 | $0.42 | $0.53 | $0.44 | $-0.22 | $0.02 | $0.27 | $0.36 | $-0.09 | $0.06 | $0.34 | $0.39 | $0.02 | $0.10 | $0.78 | $0.15 | $-0.10 | $0.17 | $0.48 | $0.17 | $0.06 | $0.38 |
| Low Forecast | $0.16 | $0.56 | $0.72 | $0.68 | $0.12 | $0.44 | $0.56 | $0.66 | $0.01 | $0.39 | $0.48 | $0.41 | $-0.45 | $0.02 | $0.25 | $0.33 | $-0.10 | $0.06 | $0.34 | $0.35 | $0.02 | $0.09 | $0.70 | $0.13 | $-0.11 | $0.15 | $0.43 | $0.15 | $0.05 | $0.34 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.90% | 0.93% | 1.23% | 0.95% | 2.55% | -29.31% | - | 0.30% | -27.78% | -3.00% | 0.19% | 0.56% | 3.97% | -15.98% | -0.18% | -0.56% | -8.55% | -0.73% |
According to 5 Wall Street analysts, PetIQ's projected average Quarter EPS for Dec 23 is $-0.32, with a low estimate of $-0.45 and a high estimate of $-0.22. This represents a -2134.84% decrease compared to PETQ previous annual EPS of $0.02 (Sep 23).
PetIQ Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions | $6.88 | $51.50 | 648.55% | Buy |
| PCRX | Pacira BioSciences | $14.35 | $43.00 | 199.65% | Hold |
| EVO | Evotec SE | $3.64 | $8.00 | 119.78% | Buy |
| BHC | Bausch Health Companies | $7.18 | $10.20 | 42.06% | Hold |
| NBIX | Neurocrine Biosciences | $122.31 | $146.60 | 19.86% | Buy |
| SUPN | Supernus Pharmaceuticals | $31.72 | $38.00 | 19.80% | Buy |
| ZTS | Zoetis | $195.71 | $227.71 | 16.35% | Buy |
| ANIP | ANI Pharmaceuticals | $60.06 | $67.33 | 12.10% | Buy |
| PBH | Prestige Consumer Healthcare | $73.55 | $82.00 | 11.49% | Buy |
| COLL | Collegium Pharmaceutical | $37.38 | $41.50 | 11.02% | Buy |
| DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
| PETQ | PetIQ | $30.76 | $31.00 | 0.78% | Buy |
| PAHC | Phibro Animal Health | $22.36 | $18.67 | -16.50% | Buy |
PETQ Forecast FAQ
Is PetIQ a good buy?
Yes, according to 3 Wall Street analysts, PetIQ (PETQ) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of PETQ's total ratings.
What is PETQ's price target?
PetIQ (PETQ) average price target is $31 with a range of $31 to $31, implying a 0.78% from its last price of $30.76. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will PetIQ stock go up soon?
According to Wall Street analysts' prediction for PETQ stock, the company can go up by 0.78% (from the last price of $30.76 to the average price target of $31), up by 0.78% based on the highest stock price target, and up by 0.78% based on the lowest stock price target.
Can PetIQ stock reach $50?
PETQ's average twelve months analyst stock price target of $31 does not support the claim that PetIQ can reach $50 in the near future.
What are PetIQ's analysts' financial forecasts?
PetIQ's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.23B (high $1.26B, low $1.18B), average EBITDA is $71.11M (high $73.34M, low $68.46M), average net income is $65.51M (high $68.19M, low $62.35M), average SG&A $215.25M (high $222.01M, low $207.26M), and average EPS is $1.88 (high $1.95, low $1.78). PETQ's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.31B (high $1.35B, low $1.26B), average EBITDA is $76.18M (high $78.57M, low $73.35M), average net income is $77.62M (high $80.78M, low $73.87M), average SG&A $230.6M (high $237.84M, low $222.04M), and average EPS is $2.22 (high $2.31, low $2.11).
Did the PETQ's actual financial results beat the analysts' financial forecasts?
Based on PetIQ's last annual report (Dec 2023), the company's revenue was $1.1M, which missed the average analysts forecast of $969.02M by -99.89%. Apple's EBITDA was $37.07K, missing the average prediction of $55.33M by -99.93%. The company's net income was $2.13K, missing the average estimation of $1.25M by -99.83%. Apple's SG&A was $196.24K, missing the average forecast of $161.47M by -99.88%. Lastly, the company's EPS was $0.0722, missing the average prediction of $0.309 by -76.62%. In terms of the last quarterly report (Dec 2023), PetIQ's revenue was $219.93K, missing the average analysts' forecast of $189.04M by -99.88%. The company's EBITDA was $-9.935K, missing the average prediction of $10.96M by -100.09%. PetIQ's net income was $-17.487K, missing the average estimation of $-11.02M by -99.84%. The company's SG&A was $42.73K, missing the average forecast of $33.18M by -99.87%. Lastly, the company's EPS was $-0.6, beating the average prediction of $-0.315 by 90.23%